These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29947477)

  • 21. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
    Bifano M; Adamczyk R; Hwang C; Kandoussi H; Marion A; Bertz RJ
    Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Jiménez-Ortigosa C; Perez WB; Angulo D; Borroto-Esoda K; Perlin DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
    McCrea JB; Macha S; Adedoyin A; Marshall W; Menzel K; Cho CR; Liu F; Zhao T; Levine V; Kraft WK; Yoon E; Panebianco D; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2019 Oct; 59(10):1331-1339. PubMed ID: 30990905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Berkow EL; Angulo D; Lockhart SR
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483955
    [No Abstract]   [Full Text] [Related]  

  • 26. Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor.
    Apgar JM; Wilkening RR; Parker DL; Meng D; Wildonger KJ; Sperbeck D; Greenlee ML; Balkovec JM; Flattery AM; Abruzzo GK; Galgoci AM; Giacobbe RA; Gill CJ; Hsu MJ; Liberator P; Misura AS; Motyl M; Nielsen Kahn J; Powles M; Racine F; Dragovic J; Fan W; Kirwan R; Lee S; Liu H; Mamai A; Nelson K; Peel M
    Bioorg Med Chem Lett; 2021 Jan; 32():127661. PubMed ID: 33160023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Second-Generation Fungerp Analog, SCY-247, Shows Potent
    Chu S; Long L; Sherif R; McCormick TS; Borroto-Esoda K; Barat S; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33317999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study.
    Tsapepas D; Saal S; Benkert S; Levine D; Delfin M; Cremers S; Amann S; Dadhania D; Kapur S; Aull M
    Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase.
    Heasley BH; Pacofsky GJ; Mamai A; Liu H; Nelson K; Coti G; Peel MR; Balkovec JM; Greenlee ML; Liberator P; Meng D; Parker DL; Wilkening RR; Apgar JM; Racine F; Hsu MJ; Giacobbe RA; Kahn JN
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6811-6. PubMed ID: 22672801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers.
    Tortorici MA; Parks V; Matschke K; Korth-Bradley J; Patat A
    Eur J Clin Pharmacol; 2013 Apr; 69(4):835-42. PubMed ID: 23052408
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H; Jeffery J; Sitar DS; Aoki FY
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
    J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination.
    Chittick GE; Zong J; Begley JA; Alianti JR; Sorbel JJ; Blum MR
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):627-36. PubMed ID: 19049696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Second-Generation Fungerp Analog, SCY-247, Shows Potent
    Chu S; Long L; McCormick TS; Borroto-Esoda K; Barat S; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
    Feng HP; Caro L; Fandozzi CM; Guo Z; Talaty J; Wolford D; Panebianco D; Iwamoto M; Butterton JR; Yeh WW
    J Clin Pharmacol; 2018 May; 58(5):666-673. PubMed ID: 29329497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.
    Itagaki F; Homma M; Yuzawa K; Nishimura M; Naito S; Ueda N; Ohkohchi N; Kohda Y
    J Pharm Pharmacol; 2004 Aug; 56(8):1055-9. PubMed ID: 15285851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.